UNSPSC 51401530: Girisopam

This classification denotes an anxiolytic with the molecular formula C18H17ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2LP301A921, chemically known as 5h-2,3-benzodiazepine, 1-(3-chlorophenyl)-7,8-dimethoxy-4-methyl- but generally known as girisopam, which bears US NIH Compound Identifier 71257. European Medicines Agency schedules Girisopam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07907MIG.

UNSPSC 51401530 Girisopam, a Commodity code, spans pharmaceutical products and medical supplies that state and local governments procure to support public health and emergency response initiatives. The recent solicitation activity under this code reflects demand for naloxone, opioid antagonists, and drug deactivation systems — products that municipalities and county health departments are acquiring to address overdose prevention and controlled substance management in community settings.

Seminole County, Florida, a county government issuing body, released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding. The county required quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The bid deadline was July 26, 2023, at 2:00 pm, and the contract was structured as a two-year initial term with a one-year renewal option on a fixed-fee basis. Vendors had to provide unit costs for each line item, maintain workers' compensation and commercial general liability insurance, comply with drug-free workplace and E-Verify requirements, and meet federal compliance standards including the Clean Air Act and Federal Water Pollution Control Act, with the procurement potentially funded through FEMA.